Microba Life Sciences Ltd (MAP)

Sydney
0.33
+0.01(+3.17%)
  • Volume:
    10,540
  • Bid/Ask:
    0.32/0.33
  • Day's Range:
    0.32 - 0.32

MAP Overview

Prev. Close
0.32
Day's Range
0.32-0.32
Revenue
2.2M
Open
0.32
52 wk Range
0.14-0.45
EPS
-0.051
Volume
10,540
Market Cap
116.6M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
249,035
P/E Ratio
-4.57
Beta
-
1-Year Change
-
Shares Outstanding
342,947,496
Next Earnings Date
28 Feb 2023
What is your sentiment on Microba Life Sciences?
or
Market is currently closed. Voting is open during market hours.

Microba Life Sciences Ltd Analysis

Microba Life Sciences Ltd Company Profile

Microba Life Sciences Ltd Company Profile

Microba Pty Limited is an Australia-based precision microbiome company. The Company's therapeutic discovery is engaged in generating multiple potent therapeutic candidates to address unmet clinical needs for multiple chronic diseases, leveraging the biology of the healthy human gut microbiome. The Company offers a range of platforms, such as Analysis Platform, Discovery Platform and Therapeutic Platform. The Company uses advanced metagenomic sequencing technology and proprietary bioinformatics tools and provides precise and comprehensive measurements of the human gut microbiome. The Company's discovery platform enables partners to access this databank for the data-driven discovery of product opportunities. The Company's therapeutic platform is a repeatable platform for microbial therapeutic leads. The Company offers research services for clinical trials for biomarker discovery for nutritional therapies.

Read More

Analyst Price Target

Average40.50 (+12,172.73% Upside)
High41.00
Low40.00
Price0.33
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralBuy
Technical IndicatorsBuySellNeutralSellStrong Buy
SummaryStrong BuyNeutralBuyNeutralStrong Buy